Cargando…
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
Monoclonal antibodies (mAbs) are increasingly being considered as agents to fight severe viral diseases. So far, they have essentially been selected and used on the basis of their virus-neutralizing activity and/or cell-killing activity to blunt viral propagation via direct mechanisms. There is, how...
Autores principales: | Pelegrin, Mireia, Naranjo-Gomez, Mar, Piechaczyk, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127033/ https://www.ncbi.nlm.nih.gov/pubmed/26433697 http://dx.doi.org/10.1016/j.tim.2015.07.005 |
Ejemplares similares
-
Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play
por: Lambour, Jennifer, et al.
Publicado: (2016) -
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
por: Perez, Norma, et al.
Publicado: (2004) -
Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy
por: Naranjo-Gomez, Mar, et al.
Publicado: (2021) -
Differential and sequential immunomodulatory role of neutrophils and Ly6C(hi) inflammatory monocytes during antiviral antibody therapy
por: Lambour, Jennifer, et al.
Publicado: (2021) -
Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
por: Pelegrin, Mireia, et al.
Publicado: (2022)